Venus Concept Inc. (NASDAQ:VERO) Sees Significant Growth in Short Interest

Venus Concept Inc. (NASDAQ:VERO) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 33,600 shares, an increase of 32.8% from the February 28th total of 25,300 shares. Based on an average daily volume of 53,100 shares, the days-to-cover ratio is presently 0.6 days. Approximately 8.9% of the company’s stock are sold short.

Venus Concept Stock Performance

Shares of VERO stock opened at $2.79 on Tuesday. The firm has a market cap of $1.84 million, a price-to-earnings ratio of -0.35 and a beta of 0.52. Venus Concept has a 52-week low of $2.33 and a 52-week high of $17.49. The company has a quick ratio of 1.18, a current ratio of 1.86 and a debt-to-equity ratio of 2.83. The company’s 50 day moving average is $3.43 and its 200 day moving average is $4.20.

Venus Concept (NASDAQ:VERO) last issued its quarterly earnings data on Monday, March 31st. The company reported ($11.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($10.01) by ($1.22). The company had revenue of $15.77 million during the quarter, compared to analysts’ expectations of $16.99 million.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.